Q-Line Biotech (NSE:QLINE) Interest Expense: ₹ Mil (TTM As of Mar. 2025)


NSE:QLINE Q-Line Biotech Ltd NSE:QLINE
12 GF Score
Price ₹546.50
! 2 Warning Signs
View Full Analysis

What is Q-Line Biotech Interest Expense?

Q-Line Biotech NSE:QLINE -5.15% 12 Interest Expense is ₹ Mil as of Mar. 2025. GuruFocus rates NSE:QLINE with a GF Score™ of 12/100. The stock has 2 warning signs investors should review.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Q-Line Biotech's interest expense for the six months ended in Mar. 2025 was ₹ -133 Mil. Q-Line Biotech does not have enough years/quarters to calculate its interest expense for the trailing twelve months (TTM) ended in Mar. 2025.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Q-Line Biotech's Operating Income for the six months ended in Mar. 2025 was ₹ 697 Mil. Q-Line Biotech's Interest Expense for the six months ended in Mar. 2025 was ₹ -133 Mil. Q-Line Biotech's Interest Coverage for the quarter that ended in Mar. 2025 was 5.25. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Q-Line Biotech  (NSE:QLINE) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Q-Line Biotech's Interest Expense for the six months ended in Mar. 2025 was ₹-133 Mil. Its Operating Income for the six months ended in Mar. 2025 was ₹697 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Mar. 2025 was ₹824 Mil.

Q-Line Biotech's Interest Coverage for the quarter that ended in Mar. 2025 is calculated as

Interest Coverage=-1* Operating Income (Q: Mar. 2025 )/Interest Expense (Q: Mar. 2025 )
=-1*696.522/-132.715
=5.25

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Q-Line Biotech Interest Expense Historical Data

* Premium members only.

The historical data trend for Q-Line Biotech's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Q-Line Biotech Interest Expense Chart

Q-Line Biotech Annual Data
Trend Mar23 Mar24 Mar25
Interest Expense
-30.75 -58.98 -132.72

Q-Line Biotech Semi-Annual Data
Mar23 Mar24 Mar25
Interest Expense -30.75 -58.98 -132.72
NSE:QLINE
12GF Score
Q-Line Biotech Ltd NSE:QLINE
Interest Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Q-Line Biotech Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Frequently Asked Questions Learn more about Interest Expense →
What does a Interest Expense of ₹ Mil mean?
Q-Line Biotech (NSE:QLINE) has a Interest Expense of ₹ Mil as of Mar. 2025. Interest Expense is the amount a company pays on its long-term debt. View historical data on Q-Line Biotech and its competitors.
Is Q-Line Biotech's Interest Expense too high?
Q-Line Biotech's current Interest Expense is ₹ Mil. Overall, Q-Line Biotech has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Q-Line Biotech's Interest Expense compare to ABT and SYK?
Q-Line Biotech's Interest Expense of ₹ Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Expense for a Medical Devices & Instruments company?
A good Interest Expense depends on the Medical Devices & Instruments industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Expense mean?
A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on Q-Line Biotech and its competitors. Q-Line Biotech's current Interest Expense is ₹ Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Q-Line Biotech stock overvalued right now?
Q-Line Biotech (NSE:QLINE) has a current Interest Expense of ₹ Mil. The current Interest Expense is ₹ Mil. Q-Line Biotech's overall GF Score™ is 12/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Expense calculated?
Interest Expense is calculated from a company's financial statements. For Q-Line Biotech (NSE:QLINE), the current Interest Expense is ₹ Mil as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Q-Line Biotech Business Description

Address Kanpur Road Adjacent Transport Nagar Metro Station, 298-281, Transport Nagar, Lucknow, UP, IND, 226012
Q-Line Biotech Ltd is engaged in the business of developing, manufacturing and marketing of diverse range of reagents (including kits and POC devices) & consumables and manufacturing, importing, distribution/supply of diagnostic equipment for different diagnostic healthcare needs. The company supplies diagnostic equipment and IVD products for different diagnostic healthcare needs directly or through its distributors majorly to diagnostic service providers, hospitals and medical colleges. It is engaged in Manufacturing and Trading into Biochemistry Regnant, Instruments and Consumables. The majority of revenue is derived from the Manufacturing segment.
12GF Score

Get the complete analysis for NSE:QLINE

Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹546.50
Price